Amnion cell-mediated immune modulation following bleomycin challenge: controlling the regulatory T cell response

Research output: Contribution to journalArticleResearchpeer-review

33 Citations (Scopus)

Abstract

The immunomodulatory properties of human amnion epithelial cells (hAECs) have been previously described in several disease models. We previously reported on the ability of hAECs to influence macrophage phenotype and chemotaxis. In this study we aim to elucidate the contribution of regulatory T cells (Tregs) to macrophage polarisation, and downstream effects on inflammation and fibrosis in a bleomycin model of lung injury. METHODS: Either CD45+/FoxP3+ Tregs or CD45+/FoxP3- non-Tregs were adoptively transferred into Rag1-/- mice immediately prior to bleomycin challenge. Four million hAECs were administered 24 hours later. Outcomes were measured 7 or 14 days later. RESULTS: Mitigation of lung inflammation and fibrosis was only observed in animals that received both hAECs and Tregs. hAEC treatment also induced the maturation of non-Tregs into FoxP3-expressing Tregs. This event was found to be TGFbeta-dependent. Further, polarisation of macrophages from M1 to M2 only occurred in animals that received hAECs and Tregs. CONCLUSIONS: This study provides the first evidence that Tregs are required for hAEC-mediated macrophage polarisation and consequential mitigation of bleomycin-induced lung injury. Uncovering the interactions between hAECs, macrophages and T cell subsets are central to an understanding of the mechanisms by which hAECs elicit lung repair.
Original languageEnglish
Article number8
Pages (from-to)1 - 12
Number of pages12
JournalStem Cell Research and Therapy
Volume6
Issue number1
DOIs
Publication statusPublished - 2015

Cite this